These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 6890181)

  • 21. Interactions between handling and acrylamide on the striatal dopamine receptor.
    Uphouse LL
    Brain Res; 1981 Sep; 221(2):421-4. PubMed ID: 7284779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential anatomical location of [3H]-N,n-propylnorapomorphine and [3H]-spiperone binding sites in the striatum and substantia nigra of the rat.
    Hall MD; Jenner P; Kelly E; Marsden CD
    Br J Pharmacol; 1983 Jun; 79(2):599-610. PubMed ID: 6418246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantification of in vivo spiperone binding in the rat striatum after lesions produced by kainate or decortication.
    Van der Werf JF; Van het Schip F; Sebens JB; Korf J
    Eur J Pharmacol; 1984 Jul; 102(3-4):387-99. PubMed ID: 6436037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of multiple receptors for dopamine.
    Spano PF; Memo M; Stefanini E; Fresia P; Trabucchi M
    Adv Biochem Psychopharmacol; 1980; 21():243-51. PubMed ID: 7376971
    [No Abstract]   [Full Text] [Related]  

  • 25. Increased 3H-spiperone binding sites in mesolimbic area related to methamphetamine-induced behavioral hypersensitivity.
    Akiyama K; Sato M; Otsuki S
    Biol Psychiatry; 1982 Feb; 17(2):223-31. PubMed ID: 7200378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of timiperone on 3H-spiroperidol binding to rat striatal dopamine receptors.
    Tachizawa H; Sudo K; Sano M
    Eur J Pharmacol; 1979 Nov; 59(3-4):245-51. PubMed ID: 43256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relationship between loss of dopamine nerve terminals, striatal [3H]spiroperidol binding and rotational behavior in unilaterally 6-hydroxydopamine-lesioned rats.
    Heikkila RE; Shapiro BS; Duvoisin RC
    Brain Res; 1981 May; 211(2):285-92. PubMed ID: 7237124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurotransmitter receptors in brain regions of acrylamide- treated rats. I: Effects of a single exposure to acrylamide.
    Agrawal AK; Seth PK; Squibb RE; Tilson HA; Uphouse LL; Bondy SC
    Pharmacol Biochem Behav; 1981 Apr; 14(4):527-31. PubMed ID: 6262842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic D-amphetamine and phencyclidine: effects on dopamine agonist and antagonist binding sites in the extrapyramidal and mesolimbic systems.
    Robertson HA
    Brain Res; 1983 May; 267(1):179-82. PubMed ID: 6860944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nigrostriatal lesions enhance striatal 3H-apomorphine and 3H-spiroperidol binding.
    Creese I; Snyder SH
    Eur J Pharmacol; 1979 Jun; 56(3):277-81. PubMed ID: 38973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of desipramine during infancy and preweanling on dorsal striatal dopamine D1 and D2 receptor binding in adolescence in the rat.
    Hilakivi I; Rinne J; Marjamäki P
    Pol J Pharmacol; 1999; 51(4):311-6. PubMed ID: 10540962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brain neurotransmitter receptor alterations in offspring of rats exposed to phenobarbital, phenytoin or their combination during pregnancy.
    Seth PK; Alleva FR; Takagi S; Yen-Koo HC; Balazs T
    Neurotoxicology; 1987; 8(1):45-53. PubMed ID: 3031564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased low-affinity 3H-spiroperidol binding to rat cortical membranes after chronic antidepressant treatments.
    Antkiewicz-Michaluk L; Rokosz-Pelc A; Vetulani J
    Pol J Pharmacol Pharm; 1985; 37(3):317-23. PubMed ID: 4070080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential inhibitory effects of ascorbic acid on the binding of dopamine agonists and antagonists to neostriatal membrane preparations: correlations with behavioral effects.
    Heikkila RE; Cabbat FS; Manzino L
    Res Commun Chem Pathol Pharmacol; 1981 Dec; 34(3):409-21. PubMed ID: 7323442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early supersensitive changes in [3H] spiroperidol binding in the isolated striatum.
    Csernansky JG; Friedhoff AJ; Bonnet KA
    Biochem Biophys Res Commun; 1982 Mar; 105(1):117-20. PubMed ID: 6124243
    [No Abstract]   [Full Text] [Related]  

  • 36. Antagonism by supidimide of haloperidol-induced augmentation of [3H]-spiperone binding in rat striatum.
    Hennies HH; Hess V; Flohé L
    Arzneimittelforschung; 1984; 34(11):1481-4. PubMed ID: 6543122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations in striatal and extrastriatal D-1 and D-2 dopamine receptors in the MPTP-treated common marmoset: an autoradiographic study.
    Gnanalingham KK; Smith LA; Hunter AJ; Jenner P; Marsden CD
    Synapse; 1993 Jun; 14(2):184-94. PubMed ID: 8332947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of [3H]spiroperidol binding by in vitro addition of ethanol.
    Hruska RE; Silbergeld EK
    J Neurochem; 1980 Sep; 35(3):750-2. PubMed ID: 7452286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurotransmitter receptors in brain regions of acrylamide- treated rats. II: Effects of extended exposure to acrylamide.
    Bondy SC; Tilson HA; Agrawal AK
    Pharmacol Biochem Behav; 1981 Apr; 14(4):533-7. PubMed ID: 6262843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modification of morphine-induced changes in striatal (3H)-spiroperidol binding and stereotype-behavior by cyclo(Leu-Gly).
    Ritzmann RF; Lee JM; Fields JZ
    Life Sci; 1982 May; 30(18):1573-80. PubMed ID: 7200563
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.